MONTA BIOSCIENCES
MonTa Biosciences is a start-up biotech company located in the science park of the largest university park in Denmark, The Danish Technical University in Kgs. Lyngby, North of Copenhagen. The company is a spin-out from a joint collaboration between DTU Nanotech, Department of Micro- and Nanotechnology, and Bioneer A/S, a research institute and CRO located in the DTU Scion Science Park in Hørsholm, Denmark. The MonTa Biosciences' technology has been developed through grants from The Danish Strategic Research Council under the NABIIT programme combining Nanotechnology, Biotechnology and IT. The technology was further developed and reached Proof-of-Principle under a Eurostars programme in collaboration between DTU Nanotech, Bioneer and the Swiss biotech Company Telormedix.
MONTA BIOSCIENCES
Industry:
Biotechnology Health Care Nanotechnology Simulation Therapeutics
Founded:
2014-01-06
Address:
Denmark, South Carolina, United States
Country:
United States
Website Url:
http://www.montabiosciences.com
Total Employee:
11+
Status:
Active
Contact:
(455)118-6306
Email Addresses:
[email protected]
Total Funding:
3.74 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Domain Not Resolving
Current Advisors List
Current Employees Featured
Founder
Investors List
Ib Kunøe
Ib Kunøe investment in Venture Round - Monta biosciences
PreSeed Ventures
PreSeed Ventures investment in Seed Round - Monta biosciences
Official Site Inspections
http://www.montabiosciences.com
- Host name: mw-04.sonnit.dk
- IP address: 83.149.93.164
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
More informations about "Monta biosciences"
Welcome to MonTa Biosciences ApS - montabiosciences.com
May 20, 2024 · MonTa Biosciences is a Clinical Stage Biotech Company with a vision to develop better cancer treatment to patients by utilizing the immune system to recognize and kill tumor …See details»
About us - montabiosciences.com
MonTa Biosciences is a clinical stage biotech company located in the science park of The Danish Technical University in Kgs. Lyngby, North of Copenhagen. Our technology encompass a …See details»
Monta biosciences - Crunchbase Company Profile & Funding
MonTa Biosciences is a start-up biotech company located in the science park of the largest university park in Denmark, The Danish Technical University in Kgs. Lyngby, North of …See details»
MonTa Biosciences - LinkedIn
MonTa Biosciences is a clinical stage biotech company located in the DTU science park in Kgs. Lyngby, Copenhagen. Our lead candidate MBS8 is a novel TLR7 agonist formulated in …See details»
Technology - montabiosciences.com
Our technology is a novel Mode of Action using Lipid Nano Particles (LNPs) with an immune stimulating small molecule drug. This approach show a strong …See details»
MonTa Biosciences - Overview, News & Competitors - ZoomInfo
View MonTa Biosciences (www.montabiosciences.com) location in Capital Region, Denmark , revenue, industry and description. Find related and similar companies as well as employees …See details»
MonTa Biosciences - VentureRadar
Website: http://montabiosciences.com/ Develops novel cancer immunotherapy treatment using systemic delivery of TLR7 formulation, activating innate immune system to combat metastatic …See details»
MonTa Biosciences ApS - Drug pipelines, Patents, Clinical trials
Explore MonTa Biosciences ApS with its drug pipeline, therapeutic area, technology platform, .See details»
Investment: MonTa BioSciences raises investment for promising …
The Copenhagen-based biotech company MonTa BioSciences Aps has just raised 2 million DKK from the incubator Pre-Seed Innovation for their promising cancer treatment. Their new cancer …See details»
MonTa BioSciences - PitchBook
Developer of cancer immunotherapy designed to boost the immune system of cancer patients.See details»
MonTa Biosciences | DANISH BIO - Dansk Biotek
MonTa Biosciences is an immuno-oncology company with our main asset being a TLR7 formulation. We have demonstrated antitumor activity in monotherapy and combination with …See details»
MonTa Biosciences Announces Investment to Complete the …
MonTa Biosciences is a clinical-stage immune oncology company working on a novel formulation of an TLR7 agonist small-molecule drug formulated in micelles termed MBS8. MBS8 is …See details»
MonTa Biosciences - Company Profile - Tracxn
Aug 23, 2024 · MonTa Biosciences - Developer of liposomes to deliver immunomodulators for the treatment of cancers. Raised a total funding of $3.97M over 3 rounds from 4 investors. Valued …See details»
MonTa Biosciences - VentureRadar
Website: http://montabiosciences.com/ Develops novel cancer immunotherapy treatment using systemic delivery of TLR7 formulation, activating innate immune system to combat metastatic …See details»
MonTa Biosciences - Products, Competitors, Financials, Employees ...
MonTa Biosciences is a Clinical Stage Biotech Company focused on developing cancer immunotherapy treatments. The company's main product, MBS8, is a novel micelle …See details»
MonTa Biosciences Company Information - Funding, Investors, …
Jan 1, 2019 · Get information on funding, investors, industries, and more for MonTa Biosciences. See MonTa Biosciences company profile and funding data.See details»
MonTa Biosciences becomes a Clinical Stage Company
MonTa Biosciences today announced that the company has transitioned from a preclinical to a Clinical stage Biotech company. MonTa has today filed our first Clinical Trial Application in …See details»
Press Release - montabiosciences.com
MonTa Biosciences is a clinical stage biotech company located in Copenhagen, Denmark, and work with a cancer immunotherapy nanoparticle called micelles, which incorporates a TLR7 …See details»
MonTa Biosciences | VentureRadar
Similar Companies: MaveriX Oncology USA Privately Held MaveriX is a globally-orientated biotechnology company focused on the discovery, development, and commercialization of …See details»
News - montabiosciences.com
MonTa Biosciences Announces Investment to Complete the Ongoing Phase I Monotherapy Trial on MBS8, and a Combination Phase IB/IIA Trial with MBS8 and a Currently Approved …See details»